Definitive Contract HT942525CE020
- Not listed
- The Department of the Army Medical Command awarded a $1,099,973.44 firm fixed price contract to Physical Sciences Inc., doing business as Physical Sciences Inc., for research and development of Stabilized, Freeze-Dried Bacteriophage for Use in Austere Environments under a Small Business Technology Transfer Phase II solicitation. The prime contractor Physical Sciences Inc. will perform the entirety of the contract from its location in Andover, Massachusetts over a period of two years from March...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Research Development and Engineering Command, a defense agency, to Physical Sciences Inc. (PSI), a for-profit research and development company located in Andover, Massachusetts. The contract has a ceiling value of $167,493.50 and is a firm fixed-price definitive contract. The contract was awarded on April 20, 2020 with a final completion date of November 30, 2020. The contract is designated as a total small...
- The Defense Health Agency awarded Physical Sciences Inc. (PSI), a small business research and development firm based in Andover, Massachusetts, a $1.1 million Phase II Small Business Innovation Research (SBIR) contract on May 25, 2023, for development of a multimodal optical imager designed to diagnose olfactory dysfunction. This total small business set-aside contract carries a firm fixed-price structure with a completion deadline of September 24, 2025. The award represents continuation of...
- This federal contract award was made by a U.S. government agency to Physical Sciences Inc. (PSI), a for-profit research and development company. The contract is for the development of a process end point monitor for lyophilized biologic drugs for cancer treatment, under the Small Business Innovation Research (SBIR) Phase I program. The contract is a definitive, firm-fixed-price contract with a ceiling value of $299,985.00. The place of performance is Andover, MA. PSI is an experienced government...
- This is a federal contract award to Physical Sciences Inc. (PSI), a for-profit research and development company, by the U.S. Army Medical Command (MEDCOM). The $1,004,849.24 contract is for a Small Business Innovation Research (SBIR) Phase II effort with a research type described as "DHP SBIR PH II PROPOSAL #H2-0163". The contract is a definitive contract with a cost-plus-fixed-fee pricing type and an ultimate completion date of January 31, 2020. This contract has a "Total Small...
- This is a $249,938.08 firm fixed-price SBIR Phase I contract awarded by the Defense Health Agency (DHA) to Physical Sciences Inc. (PSI), a small business contractor based in Andover, Massachusetts. The contract is for a DHA SBIR project titled "Degradable Polymer Nanoparticles for Controlled Drug Delivery in Treating Traumatic Brain Injury." The contract has a completion date of September 2, 2025. PSI is a for-profit research and development company that specializes in advanced...
- This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Physical Sciences Inc. (PSI), a for-profit research and development company. The definitive, firm-fixed price contract, valued at $999,586.91, is for the continuation of a prior SBIR Phase I effort. The contract has a total small business set-aside designation. Based on PSI's background, the research and development work under this contract...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Physical Sciences Inc. (PSI), a for-profit research and development company. The $1,499,946.74 firm-fixed-price contract is a continuation of an earlier SBIR Phase I effort, with a performance period through January 17, 2023. PSI has extensive experience supporting the Department of Defense, NASA, and other federal agencies through prime contracts,...
- Physical Sciences Inc., a small business research and development company based in Andover, Massachusetts, has been awarded a $1.2 million Phase II Small Business Innovation Research (SBIR) contract by Naval Strategic Systems Programs, a division of the Department of Defense. This definitive contract, awarded on February 10, 2025, with an ultimate completion date of August 11, 2026, is structured as a cost-plus-fixed-fee arrangement and carries a total small business set-aside designation. The...
- This is a $1,599,996.00 Firm Fixed Price contract awarded to Physical Sciences Inc. (PSI), a for-profit small business, by the Troop Support agency of the Department of Defense. The contract is for a Small Business Innovation Research (SBIR) Program Phase II research and development effort. The work is to be performed in Andover, MA and has a completion date of September 7, 2024. PSI has extensive experience supporting defense and civilian agencies through prime contracts, subcontracts, and...
Physical Sciences Inc., an Andover, Massachusetts-based small business specializing in advanced research and development, was awarded a $1.3M firm fixed-price contract by the Defense Health Agency under the Small Business Innovation Research (SBIR) Program Phase II. The contract, designated as a total small business set-aside, focuses on developing stabilized, freeze-dried bacteriophage for use in austere environments, with performance scheduled to conclude by January 4, 2028. The award recognizes PSI's established capabilities in innovative scientific solutions and its track record of delivering cutting-edge research across defense, aerospace, and medical sectors. This Phase II SBIR contract builds on PSI's extensive experience supporting federal research initiatives, particularly through SBIR and Small Business Technology Transfer programs across multiple agencies including the Department of Defense, NASA, and the Air Force Research Laboratory. The bacteriophage technology under development has potential applications for medical and tactical use in resource-limited operational environments, aligning with the Defense Health Agency's mission to optimize health outcomes for the military and Department of Defense personnel. The firm fixed-price structure provides cost certainty while enabling PSI to advance this specialized biotechnology solution through completion and potential transition to operational use.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 9/3/25 |